SKI Market

Indian Indices

Nifty

22,570.35 167.95
(0.75%)

Sensex

74,339.44 486.50
( 0.66%)

Bank Nifty

48,494.95 305.95
( 0.63%)

Nifty IT

33,554.45 111.90
( 0.33%)

Global Indices

Nasdaq

15,712.75 16.11
(0.10%)

Dow Jones

38,460.92 -42.77
(-0.11%)

Hang Seng

17,284.54 83.27
(0.48%)

Nikkei 225

37,628.48 -831.60
(-2.16%)

Forex

USD-INR

83.31 -0.07
(-0.09%)

EUR-INR

88.96 0.13
(0.14%)

GBP-INR

103.28 0.27
(0.26%)

JPY-INR

0.54 0.00
(-0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Corporate News - Detailed News

EQUITY - MARKET SCREENER

Back

Lupin Pharma partners with Endoceutics to commercialize Intrarosa® in Canada

09-Mar-21 11:14 Hrs IST

Lupin Pharma, a subsidiary of Lupin announced a partnership with Endoceutics, a women's health focused innovative Canadian biotech company, to commercialize Intrarosa® in Canada. Intrarosa® is Endoceutic's flagship product indicated for the treatment of postmenopausal vulvovaginal atrophy offered as a vaginal ovule containing 6.5 mg of Prasterone.

22,570.35 167.95 (0.75%)

74,339.44 486.50 ( 0.66%)

48,494.95 305.95 ( 0.63%)

33,554.45 111.90 ( 0.33%)

15,712.75 16.11 (0.10%)

38,460.92 -42.77 (-0.11%)

17,284.54 83.27 (0.48%)

37,628.48 -831.60 (-2.16%)

83.31 -0.07 (-0.09%)

88.96 0.13 (0.14%)

103.28 0.27 (0.26%)

0.54 0.00 (-0.11%)